user-icon
Cambria Alpha-Cobb

Patent Agent at Momenta Pharmaceuticals

Boston Massachusetts UNITED STATES

20180110_IUSM_NJAlves_this one
Prof. Nathan Alves

President and CEO at Indiana Lysis Technologies

Indianapolis Indiana UNITED STATES

624892-407bebba-12ba-4db6-9488-fc7f03cb7cfe
David Anderson

CNS Research Lead at Spark Therapeutics

Philadelphia Pennsylvania UNITED STATES

544533-bea5e4d9-8cb9-4652-b03d-3037d009edd5
Mr. Django Andrews

Director, Sr. Patent Counsel at Sarepta Therapeutics, Inc.

Cambridge Massachusetts UNITED STATES

639734-b23c5871-ab3a-4997-b3a0-8756a8da1587
Mark Angelicola

Senior Manager, Clinical Management at Otsuka Pharmaceutical Companies (U.S.)

user-icon
Paula Annunziato

VP, Clinical Research, GCD, Vaccines at Merck & Co., Inc.

401539
Anjan Aralihalli

Chief Business Officer; Venture Partner at GLyPharma Therapeutic; CTI Life Sciences Fund II

MOntreal Quebec CANADA

user-icon
Simon Arkell

President at Deep Lens

Columbus Ohio UNITED STATES

headshot
John Armando

Manager, Global Regulatory Affairs CMC at Biogen

Cambridge MA UNITED STATES

user-icon
Dr. Jon Arnason

Harvard Medical Faculty Physician, Hematology/Oncology at Beth Israel Deaconess Medical Center

userPhoto
Phyllis Arthur

Vice President, Infectious Diseases and Diagnostics Policy at Biotechnology Innovation Organization (BIO)

Washington District Of Columbia UNITED STATES

user-icon
Anil Asnani

VP at LabCorp

Burlington North Carolina UNITED STATES

user-icon
Jessica Atkinson

Vice President, Corporate and Business Development at Foundation Medicine

Cambridge Massachusetts UNITED STATES

619245-58f6d4cd-a3d4-4a99-ac1b-a400a75df7eb
Jim Audia

Executive Director at Chicago Biomedical Consortium

Evanston Illinois UNITED STATES